Researchers reporting in the Journal of Parkinson's Disease have found that women with Parkinson's disease, particularly those who also have Parkinson's disease dementia, show higher rates of amyloid pathology, the sticky protein buildup that is a hallmark of Alzheimer's disease. The work drew on autopsy cases from the Arizona Study of Aging and Neurodegenerative Disorders and the Brain and Body Donation Program, with 230 cases of Parkinson's examined for differences between the sexes.
Finding more than one neurodegenerative disease in the same brain was not in itself a surprise to the team. Many people arrive at a brain bank with one diagnosis and leave with evidence of several overlapping conditions. The sex difference is what stood out to the researchers, according to Dr. Driver-Dunckley, who said that mixed pathologies are common in autopsy work.
The sex difference was specific to amyloid. Women did not differ from men in tau pathology, another protein linked to Alzheimer's, and the researchers did not find a difference in levels of cognitive impairment between the groups.
The researchers say the findings could help clarify how Parkinson's and Alzheimer's relate in the brain and may point to new directions for treatment research. Anti-amyloid medications are already approved for some people diagnosed with Alzheimer's disease. Dr. Driver-Dunckley said the results raise the possibility of studying whether such treatments could someday benefit certain patients with Parkinson's dementia who also have increased amyloid pathology. That remains an open question that the study itself does not answer.